{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:13:34Z","timestamp":1778854414158,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s40121-019-00262-9","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:21:52Z","timestamp":1567228912000},"page":"569-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events"],"prefix":"10.1007","volume":"8","author":[{"given":"Abdul Razak","family":"Muttalif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica V.","family":"Presa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hammam","family":"Haridy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amgad","family":"Gamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia C.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Can\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"262_CR1","unstructured":"World Health Organization. Public health for mass gatherings: key considerations. Available at: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/162109\/WHO_HSE_GCR_2015.5_eng.pdf. Accessed December 4, 2018."},{"key":"262_CR2","unstructured":"Centers for Disease Control and Prevention. Travel to mass gatherings. Available at: https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2018\/advising-travelers-with-specific-needs\/travel-to-mass-gatherings. Accessed December 10, 2018."},{"key":"262_CR3","first-page":"14","volume":"25","author":"S Parker","year":"2010","unstructured":"Parker S. The Hajj: a constant travel destination amidst changing times. South Afr J Epidemiol Infect. 2010;25:14\u20138.","journal-title":"South Afr J Epidemiol Infect."},{"key":"262_CR4","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1016\/j.vaccine.2018.06.027","volume":"36","author":"AM Badahdah","year":"2018","unstructured":"Badahdah AM, Rashid H, Khatami A, Booy R. Meningococcal disease burden and transmission in crowded settings and mass gatherings other than Hajj\/Umrah: a systematic review. Vaccine. 2018;36:4593\u2013602.","journal-title":"Vaccine."},{"key":"262_CR5","volume-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","author":"J Hamborsky","year":"2015","unstructured":"Hamborsky J, Kroger A, Wolfe S. Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th ed. Washington: Public Health Foundation; 2015.","edition":"13"},{"key":"262_CR6","first-page":"1","volume":"62","author":"AC Cohn","year":"2013","unstructured":"Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1\u201328.","journal-title":"MMWR Recomm Rep."},{"key":"262_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1478-7954-11-17","volume":"11","author":"RZ Jafri","year":"2013","unstructured":"Jafri RZ, Ali A, Messonnier NE, et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11:11\u20137.","journal-title":"Popul Health Metr."},{"key":"262_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40121-016-0107-0","volume":"5","author":"N Crum-Cianflone","year":"2016","unstructured":"Crum-Cianflone N, Sullivan E. Meningococcal vaccinations. Infect Dis Ther. 2016;5:89\u2013112.","journal-title":"Infect Dis Ther."},{"key":"262_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","volume":"367","author":"MJ Thompson","year":"2006","unstructured":"Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367:397\u2013403.","journal-title":"Lancet"},{"key":"262_CR10","doi-asserted-by":"publisher","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","volume":"30","author":"D Pace","year":"2012","unstructured":"Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30:B3\u20139.","journal-title":"Vaccine."},{"key":"262_CR11","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(14)60381-0","volume":"383","author":"ZA Memish","year":"2014","unstructured":"Memish ZA, Zumla A, Alhakeem RF, et al. Hajj: infectious disease surveillance and control. Lancet. 2014;383:2073\u201382.","journal-title":"Lancet"},{"key":"262_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/bmj.330.7483.133","volume":"330","author":"AR Gatrad","year":"2005","unstructured":"Gatrad AR, Sheikh A. Hajj: journey of a lifetime. BMJ. 2005;330:133\u20137.","journal-title":"BMJ"},{"key":"262_CR13","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(06)68429-8","volume":"367","author":"QA Ahmed","year":"2006","unstructured":"Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. Lancet. 2006;367:1008\u201315.","journal-title":"Lancet"},{"key":"262_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.26719\/2013.19.4.389","volume":"19","author":"A Shibl","year":"2013","unstructured":"Shibl A, Tufenkeji H, Khalil M, Memish Z, Meningococcal Leadership Forum Expert Group. Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage\/travel medicine. East Mediterr Health J. 2013;19:389\u201392.","journal-title":"East Mediterr Health J."},{"key":"262_CR15","doi-asserted-by":"publisher","first-page":"19671","DOI":"10.2807\/ese.15.39.19671-en","volume":"15","author":"ZA Memish","year":"2010","unstructured":"Memish ZA. The Hajj: communicable and non-communicable health hazards and current guidance for pilgrims. Euro Surveill. 2010;15:19671.","journal-title":"Euro Surveill"},{"key":"262_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(89)90439-X","volume":"2","author":"PS Moore","year":"1989","unstructured":"Moore PS, Reeves MW, Schwartz B, Gellin BG, Broome CV. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet. 1989;2:260\u20133.","journal-title":"Lancet"},{"key":"262_CR17","doi-asserted-by":"publisher","first-page":"20581","DOI":"10.2807\/1560-7917.ES2013.18.37.20581","volume":"18","author":"Z Memish","year":"2013","unstructured":"Memish Z, Al Hakeem R, Al Neel O, et al. Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995\u20132011. Euro Surveill. 2013;18:20581.","journal-title":"Euro Surveill."},{"key":"262_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijid.2015.12.010","volume":"47","author":"S Yezli","year":"2016","unstructured":"Yezli S, Bin Saeed AA, Assiri AM, et al. Prevention of meningococcal disease during the Hajj and Umrah mass gatherings: past and current measures and future prospects. Int J Infect Dis. 2016;47:71\u20138.","journal-title":"Int J Infect Dis."},{"key":"262_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-61779-346-2_1","volume":"799","author":"NG Rouphael","year":"2012","unstructured":"Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012;799:1\u201320.","journal-title":"Methods Mol Biol"},{"key":"262_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijid.2016.04.007","volume":"47","author":"S Yezli","year":"2016","unstructured":"Yezli S, Assiri AM, Alhakeem RF, Turkistani AM, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:60\u20134.","journal-title":"Int J Infect Dis."},{"key":"262_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1017\/S0950268800058556","volume":"115","author":"YM al-Gahtani","year":"1995","unstructured":"al-Gahtani YM, el-Bushra HE, al-Qarawi SM, al-Zubaidi AA, Fontaine RE. Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992. Epidemiol Infect. 1995;115:399\u2013409.","journal-title":"Epidemiol Infect."},{"key":"262_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0924-8579(02)00356-4","volume":"21","author":"HH Balkhy","year":"2003","unstructured":"Balkhy HH, Memish ZA, Osoba AO. Meningococcal carriage among local inhabitants during the pilgrimage 2000\u20132001. Int J Antimicrob Agents. 2003;21:107\u201311.","journal-title":"Int J Antimicrob Agents"},{"key":"262_CR23","first-page":"125","volume":"48","author":"J Cummiskey","year":"2008","unstructured":"Cummiskey J, Borrione P, Bachil N, Ergen E, Pigozzi F. Report of a serious reportable communicable disease at a major sporting event. J Sports Med Phys Fitness. 2008;48:125\u20138.","journal-title":"J Sports Med Phys Fitness"},{"key":"262_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5365\/wpsar.2016.7.3.007","volume":"8","author":"M Kanai","year":"2017","unstructured":"Kanai M, Kamiya H, Smith-Palmer A, et al. Meningococcal disease outbreak related to the World Scout Jamboree in Japan, 2015. West Pac Surveill Response J. 2017;8:25\u201330.","journal-title":"West Pac Surveill Response J."},{"key":"262_CR25","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.4161\/hv.28951","volume":"10","author":"H Tezer","year":"2014","unstructured":"Tezer H, Ozkaya-Parlakay A, Kanik-Yuksek S, Gulhan B, Guldemir D. A Syrian patient diagnosed with meningococcal meningitis serogroup B. Hum Vaccin Immunother. 2014;10:2482.","journal-title":"Hum Vaccin Immunother."},{"key":"262_CR26","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3201\/eid2305.161713","volume":"23","author":"P Stefanelli","year":"2017","unstructured":"Stefanelli P, Neri A, Vacca P, et al. Meningococci of serogroup X clonal complex 181 in refugee camps, Italy. Emerg Infect Dis. 2017;23:870\u20132.","journal-title":"Emerg Infect Dis."},{"key":"262_CR27","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.15585\/mmwr.mm6642a4","volume":"66","author":"J Doedeh","year":"2017","unstructured":"Doedeh J, Frimpong JA, Yealue KDM 2nd, et al. Rapid field response to a cluster of illnesses and deaths\u2014Sinoe County, Liberia, April\u2013May, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:1140\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"262_CR28","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.15585\/mmwr.mm6642a5","volume":"66","author":"JC Patel","year":"2017","unstructured":"Patel JC, George J, Vuong J, et al. Rapid laboratory identification of Neisseria meningitidis serogroup C as the cause of an outbreak\u2014Liberia, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:1144\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"262_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cmi.2014.11.021","volume":"21","author":"S Sridhar","year":"2015","unstructured":"Sridhar S, Gautret P, Brouqui P. A comprehensive review of the Kumbh Mela: identifying risks for spread of infectious diseases. Clin Microbiol Infect. 2015;21:128\u201333.","journal-title":"Clin Microbiol Infect"},{"key":"262_CR30","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.rmed.2007.06.030","volume":"101","author":"K Prasad","year":"2007","unstructured":"Prasad K, Karlupia N. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews. Respir Med. 2007;101:2037\u201343.","journal-title":"Respir Med"},{"key":"262_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2515135518781757","volume":"6","author":"P Balmer","year":"2018","unstructured":"Balmer P, York LJ. Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control. Ther Adv Vaccines Immunother. 2018;6:49\u201360.","journal-title":"Ther Adv Vaccines Immunother."},{"key":"262_CR32","doi-asserted-by":"publisher","first-page":"e19513","DOI":"10.1371\/journal.pone.0019513","volume":"6","author":"I Delrieu","year":"2011","unstructured":"Delrieu I, Yaro S, Tamekloe TA, et al. Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS One. 2011;6:e19513.","journal-title":"PLoS One"},{"key":"262_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/S1473-3099(18)30400-6","volume":"18","author":"WH Chen","year":"2018","unstructured":"Chen WH, Neuzil KM, Boyce CR, et al. Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study. Lancet Infect Dis. 2018;18:1088\u201396.","journal-title":"Lancet Infect Dis."},{"key":"262_CR34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.vaccine.2012.12.022","volume":"31","author":"E Hong","year":"2013","unstructured":"Hong E, Giuliani MM, Deghmane AE, et al. Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine. 2013;31:1113\u20136.","journal-title":"Vaccine."},{"key":"262_CR35","doi-asserted-by":"crossref","unstructured":"Harris S, Tan C, Andrew L, et al. Trumenba\u00ae elicits bactericidal antibodies against non\u2013serogroup B meningococci. Presented at: European Society for Paediatric Infectious Diseases, May 23\u201327, 2017; Madrid, Spain.","DOI":"10.26226\/morressier.58fa1764d462b80290b50a02"},{"key":"262_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","volume":"19","author":"LH Harrison","year":"2006","unstructured":"Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev. 2006;19:142\u201364.","journal-title":"Clin Microbiol Rev"},{"key":"262_CR37","first-page":"237","volume":"4","author":"Q Chang","year":"2012","unstructured":"Chang Q, Tzeng YL, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol. 2012;4:237\u201345.","journal-title":"Clin Epidemiol"},{"key":"262_CR38","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1080\/21645515.2018.1451810","volume":"14","author":"AW Dretler","year":"2018","unstructured":"Dretler AW, Rouphael NG, Stephens DS. Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Hum Vaccin Immunother. 2018;14:1146\u201360.","journal-title":"Hum Vaccin Immunother."},{"key":"262_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","volume":"108","author":"A Ali","year":"2014","unstructured":"Ali A, Jafri RZ, Messonnier N, et al. Global practices of meningococcal vaccine use and impact on invasive disease. Pathog Glob Health. 2014;108:11\u201320.","journal-title":"Pathog Glob Health."},{"key":"262_CR40","first-page":"85","volume":"7","author":"CP Hedari","year":"2014","unstructured":"Hedari CP, Khinkarly RW, Dbaibo GS. Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Infect Drug Resist. 2014;7:85\u201399.","journal-title":"Infect Drug Resist."},{"key":"262_CR41","unstructured":"Menactra\u00ae (MCV4). Full prescribing information. Rockville: Sanofi Pasteur, 2011."},{"key":"262_CR42","unstructured":"Menveo\u00ae (meningococcal [groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine). Summary of Product Characteristics, GSK Vaccines, Srl, Via Fiorentia, Italy, 2017."},{"key":"262_CR43","unstructured":"Nimenrix\u00ae, Product Monograph. Kirkland: Pfizer Canada Inc; 2016."},{"key":"262_CR44","unstructured":"Trumenba\u00ae (meningococcal group B vaccine). Full Prescribing Information. Philadelphia: Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc, 2016."},{"key":"262_CR45","unstructured":"Bexsero\u00ae (meningococcal group B vaccine). Full Prescribing Information. Cambridge: Novartis, 2016."},{"key":"262_CR46","first-page":"608","volume":"64","author":"T Folaranmi","year":"2015","unstructured":"Folaranmi T, Rubin L, Martin SW, et al. Use of serogroup B meningococcal vaccines in persons aged\u2009\u2265\u200910\u00a0years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:608\u201312.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"262_CR47","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1086\/597806","volume":"199","author":"PT Beernink","year":"2009","unstructured":"Beernink PT, Caugant DA, Welsch JA, Koeberling O, Granoff DM. Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. J Infect Dis. 2009;199:1360\u20138.","journal-title":"J Infect Dis"},{"key":"262_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4161\/hv.7.0.14564","volume":"7","author":"SL Harris","year":"2011","unstructured":"Harris SL, Zhu D, Murphy E, et al. Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis serogroup C disease. Human Vaccines. 2011;7:68\u201374.","journal-title":"Human Vaccines."},{"key":"262_CR49","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1016\/j.vaccine.2018.05.081","volume":"36","author":"SL Harris","year":"2018","unstructured":"Harris SL, Tan C, Andrew L, et al. The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci. Vaccine. 2018;36:6867\u201374.","journal-title":"Vaccine."},{"key":"262_CR50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3201\/eid0808.010422","volume":"8","author":"JF Aguilera","year":"2002","unstructured":"Aguilera JF, Perrocheau A, Meffre C, Hahne S, W135 Working Group. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis. 2002;8:761\u20137.","journal-title":"Emerg Infect Dis."},{"key":"262_CR51","volume-title":"CDC Yellow Book 2018: health information for international travel","author":"JR MacNeil","year":"2017","unstructured":"MacNeil JR, Meyer SA. Chapter 3 Infectious Diseases Related to Travel: Meningococcal Disease. In: Centers for Disease Control and Prevention, Brunette GW, editors. CDC Yellow Book 2018: health information for international travel. New York: Oxford University Press; 2017."},{"key":"262_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1708-8305.2011.00575.x","volume":"19","author":"ZA Memish","year":"2012","unstructured":"Memish ZA, Assiri AM, Hussain R, Alomar I, Stephens G. Detection of respiratory viruses among pilgrims in Saudi Arabia during the time of a declared influenza A(H1N1) pandemic. J Travel Med. 2012;19:15\u201321.","journal-title":"J Travel Med."},{"key":"262_CR53","unstructured":"International Association for Medical Assistance to Travellers. Saudia Arabia required vaccinations: meningococcal meningitis. Available at: https:\/\/www.iamat.org\/country\/saudi-arabia\/risk\/meningococcal-meningitis. Accessed December 12, 2018."},{"key":"262_CR54","unstructured":"International Association for Medical Assistance to Travellers. Italy recommended vaccinations: routine immunizations. Available at: https:\/\/www.iamat.org\/country\/italy\/risk\/routine-immunizations. Accessed December 12, 2018."},{"key":"262_CR55","unstructured":"International Association for Medical Assistance to Travellers. Turkey recommended vaccinations: routine immunizations. Available at: https:\/\/www.iamat.org\/country\/turkey\/risk\/routine-immunizations. Accessed December 12, 2018."},{"key":"262_CR56","unstructured":"International Association for Medical Assistance to Travellers. Spain recommended vaccinations: routine immunizations. Available at: https:\/\/www.iamat.org\/country\/spain\/risk\/routine-immunizations. Accessed January 7, 2019."},{"key":"262_CR57","unstructured":"International Association for Medical Assistance to Travellers. Japan recommended vaccinations: routine immunizations. Available at: https:\/\/www.iamat.org\/country\/japan\/risk\/routine-immunizations. Accessed January 7, 2019."},{"key":"262_CR58","unstructured":"MenAfriVac\u00ae (Meningococcal A conjugate vaccine lyophilized [PsA-TT]). Full Prescribing Information. Hadapsar: Serum Institute of India Pvt. Ltd. 2015."},{"key":"262_CR59","unstructured":"Trumenba (MenB-FHbp). Full Prescribing Information. Philadelphia: Pfizer Inc, 2018."},{"key":"262_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/21645515.2017.1264750","volume":"13","author":"RG Donald","year":"2017","unstructured":"Donald RG, Hawkins JC, Hao L, et al. Meningococcal serogroup B vaccines: estimating breadth of coverage. Hum Vaccin Immunother. 2017;13:255\u201365.","journal-title":"Hum Vaccin Immunother."},{"key":"262_CR61","unstructured":"NeisVac-C\u00ae Vaccine. Product Monograph. Kirkland: Pfizer Canada Inc, 2015."},{"key":"262_CR62","unstructured":"Menitorix\u00ae (meningococcal polysaccharide conjugate vaccine [Hib-MenC]). Full Prescribing Information. Victoria: GlaxoSmithKline, 2016."},{"key":"262_CR63","unstructured":"Menjugate\u00ae Product Monograph. Siena: Novartis Vaccines and Diagnostics; 2013."},{"key":"262_CR64","unstructured":"Meningitec\u00ae 0.5\u00a0mL. Product Information. West Ryde, New South Wales, Australia: Pfizer Australia Pty Ltd; 2011."},{"key":"262_CR65","unstructured":"MENHIBRIX\u00ae (Hib-MenCY-TT). Full Prescribing Information. Rixensart: GlaxoSmithKline, 2013."},{"key":"262_CR66","unstructured":"Menveo\u00ae (meningococcal [groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine). Full Prescribing Information. Sovicille: Novartis, 2013."},{"key":"262_CR67","unstructured":"Nimenrix (meningococcal group A, C, W-135 and Y conjugate vaccine). Summary of Product Characteristics. Sandwich: Pfizer Limited, 2017."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-019-00262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-019-00262-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-019-00262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T06:25:57Z","timestamp":1715667957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-019-00262-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1007\/s40121-019-00262-9","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}